Mathias et al. [79] found that OCRE can deplete CD8+CD20+ T cells and reduce their expression levels of CXCR3 and CNS-related lymphocyte function-associated antigen 1 (LFA-1) integrin to inhibit the development of MS. The gene discussed is CXCR3; the disease is myeloid sarcoma.